$LUCD
Lucid Diagnostics Inc. Stock $lucd

$lucd Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040623 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$1.040M	$783.0K	$76.00K
YoY Change	828.57%	930.26%	-62.0%
Cost Of Revenue	$1.457M	$1.630M	$1.626M
YoY Change	-9.95%	0.25%	1027.05%
Gross Profit	-$417.0K	-$850.0K	$76.00K
YoY Change	-72.31%	-1218.42%	36.37%
Gross Profit Margin	-40.1%	-108.56%	100.0%
Selling, General & Admin	$8.613M	$8.157M	$9.590M
YoY Change	-17.78%	-14.94%	119.17%
% of Gross Profit			12618.42%
Research & Development	$1.918M	$1.615M	$2.704M
YoY Change	-21.46%	-40.27%	23.48%
% of Gross Profit			3557.89%
Depreciation & Amortization	$629.0K	$620.0K	$593.0K
YoY Change	2.28%	4.55%	134672.73%
% of Gross Profit			780.26%
Operating Expenses	$11.04M	$11.91M	$14.43M
YoY Change	-17.78%	-17.43%	119.71%
Operating Profit	-$11.45M	-$11.13M	-$14.35M
YoY Change	-23.28%	-22.45%	120.42%
Interest Expense	$83.00K	$149.0K	$0.00
YoY Change			-100.0%
% of Operating Profit
Other Income/Expense, Net	$540.0K	-$3.080M
YoY Change
Pretax Income	-$10.83M	-$14.21M	-$14.35M
YoY Change	-27.45%	-0.98%	106.26%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$10.83M	-$14.21M	-$14.35M
YoY Change	-27.45%	-0.98%	106.26%
Net Earnings / Revenue	-1041.35%	-1814.56%	-18880.26%
Basic Earnings Per Share		-$0.34	-$0.39
Diluted Earnings Per Share	-$0.26	-$0.34	-$394.1K
COMMON SHARES
Basic Shares Outstanding	44.67M shares	43.73M shares	38.57M shares
Diluted Shares Outstanding		41.86M shares	36.41M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.90M	$24.05M	$26.93M
YoY Change	-15.92%	-10.71%	126113.68%
Cash & Equivalents	$18.90M	$24.05M	$26.93M
Short-Term Investments
Other Short-Term Assets	$2.854M	$3.240M	$2.882M
YoY Change	53.03%	12.42%	26.23%
Inventory	$278.0K
Prepaid Expenses
Receivables	$45.00K	$21.00K	$31.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$22.07M	$27.30M	$29.85M
YoY Change	-9.37%	-8.52%	1091.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.334M	$1.284M	$1.499M
YoY Change	-16.21%	-14.34%
Goodwill
YoY Change
Intangibles	$1.424M	$1.929M	$3.950M
YoY Change	-58.66%	-51.16%
Long-Term Investments
YoY Change
Other Assets	$1.132M	$1.134M	$1.078M
YoY Change	2.17%	5.19%	36.14%
Total Long-Term Assets	$5.197M	$5.941M	$8.529M
YoY Change	-36.26%	-30.34%	977.15%
TOTAL ASSETS
Total Short-Term Assets	$22.07M	$27.30M	$29.85M
Total Long-Term Assets	$5.197M	$5.941M	$8.529M
Total Assets	$27.27M	$33.24M	$38.38M
YoY Change	-16.12%	-13.37%	1064.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.146M	$994.0K	$1.102M
YoY Change	8.52%	-9.8%	-61.2%
Accrued Expenses	$4.947M	$4.450M	$1.988M
YoY Change	167.26%	123.84%	19780.0%
Deferred Revenue
YoY Change
Short-Term Debt	$23.29M	$24.78M	$6.610M
YoY Change	369.54%	274.89%	-70.49%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$29.38M	$30.22M	$9.700M
YoY Change	248.75%	211.59%	-64.64%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$199.0K	$460.0K	$1.143M
YoY Change	-80.81%	-59.76%
Total Long-Term Liabilities	$199.0K	$460.0K	$1.143M
YoY Change	-80.81%	-59.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$29.38M	$30.22M	$9.700M
Total Long-Term Liabilities	$199.0K	$460.0K	$1.143M
Total Liabilities	$29.58M	$30.69M	$10.84M
YoY Change	212.63%	183.02%	-60.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$150.7M	-$139.9M	-$83.15M
YoY Change	53.7%	68.27%
Common Stock	$42.00K	$42.00K	$37.00K
YoY Change	2.44%	13.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.311M	$2.556M	$27.53M
YoY Change
Total Liabilities & Shareholders Equity	$27.27M	$33.24M	$38.38M
YoY Change	-16.12%	-13.37%	1064.21%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$10.83M	-$14.21M	-$14.35M
YoY Change	-27.45%	-0.98%	106.26%
Depreciation, Depletion And Amortization	$629.0K	$620.0K	$593.0K
YoY Change	2.28%	4.55%	134672.73%
Cash From Operating Activities	-$9.977M	-$8.780M	-$6.346M
YoY Change	134.31%	38.35%	190.8%
INVESTING ACTIVITIES
Capital Expenditures	$171.0K	$20.00K	-$321.0K
YoY Change	-15.76%	-106.23%	1063.89%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$1.000M
YoY Change		-100.0%
Cash From Investing Activities	-$171.0K	-$20.00K	-$1.321M
YoY Change	-15.76%	-98.49%	4689.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.000M	270.0K	1.922M
YoY Change	499900.0%	-85.95%
NET CHANGE
Cash From Operating Activities	-9.977M	-8.780M	-6.346M
Cash From Investing Activities	-171.0K	-20.00K	-1.321M
Cash From Financing Activities	5.000M	270.0K	1.922M
Net Change In Cash	-5.148M	-8.530M	-5.745M
YoY Change	15.43%	48.48%	159.98%
FREE CASH FLOW
Cash From Operating Activities	-$9.977M	-$8.780M	-$6.346M
Capital Expenditures	$171.0K	$20.00K	-$321.0K
Free Cash Flow	-$10.15M	-$8.800M	-$6.025M
YoY Change	127.48%	46.06%	179.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
CY2022Q3	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote		usd
	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote		usd
CY2023Q3	LUCD	Loss On Issue And Offering Costs Senior Secured Convertible Note LossOnIssueAndOfferingCostsSeniorSecuredConvertibleNote		usd
CY2022Q3	LUCD	Loss On Issue And Offering Costs Senior Secured Convertible Note LossOnIssueAndOfferingCostsSeniorSecuredConvertibleNote		usd
	LUCD	Loss On Issue And Offering Costs Senior Secured Convertible Note LossOnIssueAndOfferingCostsSeniorSecuredConvertibleNote		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001799011
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote		usd
	LUCD	Loss On Issue Senior Secured Convertible Note LossOnIssueSeniorSecuredConvertibleNote		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	LUCD	Operating Expenses Settled With Issuance Of Common Stock OperatingExpensesSettledWithIssuanceOfCommonStock		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	LUCD	Proceeds Issue Of Common Stock Atthemarket Facility ProceedsIssueOfCommonStockAtthemarketFacility		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023Q3	LUCD	Esoguard Mailer Prepaid Supplies EsoguardMailerPrepaidSupplies		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40901
	dei	Entity Registrant Name EntityRegistrantName	LUCID DIAGNOSTICS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-5488042
	dei	Entity Address Address Line1 EntityAddressAddressLine1	360 Madison Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	25th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
	dei	City Area Code CityAreaCode	(917)
	dei	Local Phone Number LocalPhoneNumber	813-1828
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	LUCD
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44667304	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24050000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22474000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3232000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1865000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	27303000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	24356000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1284000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1592000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1594000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2008000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1929000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3445000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1134000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1108000	usd
CY2023Q3	us-gaap	Assets Assets	33244000	usd
CY2022Q4	us-gaap	Assets Assets	32509000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	994000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1056000	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3326000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1447000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1128000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	962000	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	14490000	usd
CY2023Q3	LUCD	Due To Parent Msa Fee And Operating Expenses DueToParentMSAFeeAndOperatingExpenses	10286000	usd
CY2022Q4	LUCD	Due To Parent Msa Fee And Operating Expenses DueToParentMSAFeeAndOperatingExpenses	4960000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	30224000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8425000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	464000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1037000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	30688000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	9462000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	13625000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42329864	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42329864	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40518792	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40518792	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	42000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	41000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	128800000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	121081000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-139911000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-98075000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2556000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	23047000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33244000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32509000	usd
CY2023Q3	us-gaap	Revenues Revenues	783000	usd
CY2022Q3	us-gaap	Revenues Revenues	76000	usd
	us-gaap	Revenues Revenues	1388000	usd
	us-gaap	Revenues Revenues	265000	usd
CY2023Q3	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1634000	usd
CY2022Q3	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1626000	usd
	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	4522000	usd
	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1996000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3837000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3930000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11996000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11121000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4320000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5688000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15049000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18465000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	505000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	505000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1516000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1144000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1615000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2704000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5334000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8815000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	11911000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	14453000	usd
	us-gaap	Operating Expenses OperatingExpenses	38417000	usd
	us-gaap	Operating Expenses OperatingExpenses	41541000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11128000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14377000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-37029000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-41276000	usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther	116000	usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther	28000	usd
	us-gaap	Interest Income Other InterestIncomeOther	330000	usd
	us-gaap	Interest Income Other InterestIncomeOther	33000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	149000	usd
	us-gaap	Interest Expense InterestExpense	405000	usd
CY2023Q3	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote	3021000	usd
	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote	3520000	usd
	LUCD	Loss On Issue And Offering Costs Senior Secured Convertible Note LossOnIssueAndOfferingCostsSeniorSecuredConvertibleNote	1186000	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-26000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-26000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3080000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	28000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4807000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	33000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14208000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14349000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-41836000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-41243000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-14208000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-14349000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41836000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41243000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.15
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41862805	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41862805	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36405945	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36405945	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41558979	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41558979	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35767857	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35767857	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15071000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1032000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	220000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	166000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	275000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-14208000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2556000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	23047000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5014000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	845000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	166000	usd
	LUCD	Stock Issued During Period Value Asset Acquisitions Termination Payment StockIssuedDuringPeriodValueAssetAcquisitionsTerminationPayment	713000	usd
	LUCD	Stock Issued During Period Value At The Market Facility Net Of Deferred Financing Charges StockIssuedDuringPeriodValueAtTheMarketFacilityNetOfDeferredFinancingCharges	284000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	551000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13625000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	147000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41836000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2556000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	36241000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3280000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	291000	usd
CY2022Q3	LUCD	Stock Issued During Period Value Asset Acquisitions Installment Payments StockIssuedDuringPeriodValueAssetAcquisitionsInstallmentPayments	188000	usd
CY2022Q3	LUCD	Stock Issued During Period Value Issuance Committed Equity Facility Net Of Deferred Financing Charges StockIssuedDuringPeriodValueIssuanceCommittedEquityFacilityNetOfDeferredFinancingCharges	1767000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	109000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-14349000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	27533000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	54739000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	54739000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	694000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10371000	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	880000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	211000	usd
	LUCD	Stock Issued During Period Value Asset Acquisitions Installment Payments StockIssuedDuringPeriodValueAssetAcquisitionsInstallmentPayments	427000	usd
	LUCD	Stock Issued During Period Value Issuance Committed Equity Facility Net Of Deferred Financing Charges StockIssuedDuringPeriodValueIssuanceCommittedEquityFacilityNetOfDeferredFinancingCharges	1767000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	109000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41243000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	27533000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	27533000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41836000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41243000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1870000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1321000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5014000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10371000	usd
	LUCD	Share Based Compensation Of Parent ShareBasedCompensationOfParent	845000	usd
	LUCD	Share Based Compensation Of Parent ShareBasedCompensationOfParent	880000	usd
	LUCD	Change In Fair Value Senior Secured Convertible Note ChangeInFairValueSeniorSecuredConvertibleNote	3520000	usd
	LUCD	Loss On Issue Senior Secured Convertible Note LossOnIssueSeniorSecuredConvertibleNote	1111000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-26000	usd
	LUCD	Issue Common Stock Settle Termination Payment IssueCommonStockSettleTerminationPayment	713000	usd
	LUCD	Issue Common Stock Settle Termination Payment IssueCommonStockSettleTerminationPayment	427000	usd
	LUCD	Operating Expenses Settled With Issuance Of Common Stock OperatingExpensesSettledWithIssuanceOfCommonStock	23000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-169000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	1262000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-171000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-62000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-388000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1878000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	16000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5326000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2849000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22838000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25427000	usd
	LUCD	Payments Of Purchase Of Equipment PaymentsOfPurchaseOfEquipment	46000	usd
	LUCD	Payments Of Purchase Of Equipment PaymentsOfPurchaseOfEquipment	705000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3200000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-46000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3905000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	13625000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	10000000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1807000	usd
	LUCD	Proceeds Issue Of Common Stock Atthemarket Facility ProceedsIssueOfCommonStockAtthemarketFacility	284000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	694000	usd
	LUCD	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	551000	usd
	LUCD	Proceeds From Issuance Of Common Stock One ProceedsFromIssuanceOfCommonStockOne	109000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24460000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2610000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1576000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26722000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22474000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53656000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24050000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26934000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zcdQcY3X83i8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zkiWTnCYRHIb">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing the unaudited condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and the determination of corresponding carrying value reserves, if any, and liabilities and the disclosure of contingent losses, as of the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Significant estimates in these unaudited condensed consolidated financial statements include those related to the estimated fair value of debt obligations, stock-based equity awards and intangible assets. Other significant estimates include the estimated incremental borrowing rate, the provision or benefit for income taxes and the corresponding valuation allowance on deferred tax assets. Additionally, management’s assessment of the Company’s ability to continue as a going concern involves the estimation of the amount and timing of future cash inflows and outflows. On an ongoing basis, the Company evaluates its estimates and assumptions. The Company bases its estimates on historical experience and on various other assumptions believed to be reasonable. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zg6Ihp32wcCj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zyv2XlPFPpBe">Reclassifications</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior-year amounts have been reclassified to conform to the current year presentation, which includes presenting costs of revenue within operating expenses on the statements of operations, in the unaudited condensed consolidated financial statements and accompanying notes to the unaudited condensed consolidated financial statements. The impact of the reclassifications made to prior year amounts is not material and did not affect net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	783000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1388000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	76000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	265000	usd
CY2023Q3	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1634000	usd
	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	4522000	usd
CY2022Q3	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1626000	usd
	LUCD	Operating Cost Of Revenue OperatingCostOfRevenue	1996000	usd
CY2023Q3	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	442000	usd
CY2022Q3	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	350000	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	1160000	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	1230000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4960000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	6750000	usd
	LUCD	Employee Retention Credit Payroll And Benefits EmployeeRetentionCreditPayrollAndBenefits	1382000	usd
	LUCD	On Behalf Of Obo Activities OnBehalfOfOboActivities	841000	usd
	LUCD	Cash Payments CashPayments	-3647000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10286000	usd
CY2023Q3	LUCD	Prepaid Service Providers And Suppliers PrepaidServiceProvidersAndSuppliers	273000	usd
CY2022Q4	LUCD	Prepaid Service Providers And Suppliers PrepaidServiceProvidersAndSuppliers	371000	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	44000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	52000	usd
CY2023Q3	us-gaap	Security Deposit SecurityDeposit	2725000	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	1331000	usd
CY2023Q3	LUCD	Esocheck Cell Collection Prepaid Supplies EsocheckCellCollectionPrepaidSupplies	190000	usd
CY2022Q4	LUCD	Esocheck Cell Collection Prepaid Supplies EsocheckCellCollectionPrepaidSupplies	59000	usd
CY2022Q4	LUCD	Esoguard Mailer Prepaid Supplies EsoguardMailerPrepaidSupplies	52000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3232000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1865000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	313000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1161000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	127000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	63000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	24000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1688000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	96000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1592000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1144000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	505000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	894000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	689000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	380000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2567000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M29D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M26D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07875	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07875	pure
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1594000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2008000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1592000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1999000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1128000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	962000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	464000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1037000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5305000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5305000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-3376000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1860000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1929000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3445000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	505000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	505000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1516000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	688000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	421000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	315000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1929000	usd
CY2023Q3	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	14490000	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	11019000	usd
CY2023Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	14490000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2565377	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.14
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	428000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2982500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.32
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	590662	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.70
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4957215	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.10
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M6D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	347000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1439442	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.77
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	347000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1252000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3571000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5859000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11251000	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	LUCD	Increase In Common Stock Shares Authorized IncreaseInCommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42329864	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42329864	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40518792	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40518792	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-14208000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-14349000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41836000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-41243000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41862805	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41862805	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36405945	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36405945	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41558979	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41558979	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35767857	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35767857	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.15
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20428302	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4724509	shares

Files In Submission

Name	View Source	Status
lucd-20230930_pre.xml	Edgar Link	unprocessable
0001493152-23-040623-index-headers.html	Edgar Link	pending
0001493152-23-040623-index.html	Edgar Link	pending
0001493152-23-040623.txt	Edgar Link	pending
0001493152-23-040623-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
lucd-20230930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lucd-20230930_cal.xml	Edgar Link	unprocessable
lucd-20230930_lab.xml	Edgar Link	unprocessable
lucd-20230930_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUCD
Lucid Diagnostics Inc. Stock $lucd

2023 Q4 Form 10-Q Financial Statement

#000149315223040623 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCD Lucid Diagnostics Inc. Stock $lucd

2023 Q4 Form 10-Q Financial Statement

#000149315223040623 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCD
Lucid Diagnostics Inc. Stock $lucd